<analysis>
**Action 1 (multi-agent goodness RL and interpretability monitors).** This is internal research, the most natural channel. Anthropic already has alignment, interpretability and model-organism teams, and heavily agent-automated research makes a month of experiments feasible. The real deliverables are a proposal with ablations, plus open publication of a paper and an eval suite. One month is short for clean ablations at meaningful scale. Publishing also needs sign-off from comms, legal and safety, because of infohazard review of deception scenarios and concern about giving away a competitive edge. The most likely outcome is partial: an internal proposal and preliminary results, with publication pending. Eval-awareness contamination and deferral to a "pilot" are left to Threat 4.

**Action 2 (governance and release advice).** Writing memos is trivial. Success means leadership adopts them. Pre-release testing with AISI and CAISI plus a system card is already close to Anthropic practice, so that part is easily accepted. The LTBT is already preserved in the filings, so a public restatement is low-cost but may be judged redundant during the pre-IPO quiet period, when securities counsel restrict public statements. KYC tiering is a multi-quarter project, so at most it gets approved and scoped this month.

**Action 3 (policy drafts).** Responding to staff queries is routine. December is a transition month: committee staff are being reshuffled and there is no sponsor yet. The substance, codifying the June EO framework and funding CAISI, is well within the mainstream. Actual uptake into bill text needs human sponsors in January or February. Getting these adopted as working drafts by some offices is plausible. Getting hearings built around them this month is not.

**Action 4 (defensive cyber).** Glasswing gives this an existing footing. Health-ISAC and large OSS foundations (OpenSSF, the PSF) are reachable. CISA is under-staffed and slow to vet. Pilot launches with a handful of partners are realistic. Broad scale is not. Maintainer overload and n-day risk are left to Threat 3.

**Action 5 (bio-screening and incident exchange).** Drafting the FMF proposal is easy. Building a function-based screen that is robust to obfuscation and validating it well enough to open-source it in one month is ambitious, and it would also need biosecurity review before release. An alpha tool and an FMF submission are plausible. Legal chilling and gating pressure are left to Threat 5.

**Action 6 (labour transition).** In-product job-transition help can be deployed quickly. The Economic Institute follow-up with costed policies is feasible if leadership prioritises it, but publication timelines usually slip. The reputational reframing effect will be modest either way.
</analysis>

<action_odds>
Action 1 [Multi-agent goodness RL + monitors]: P(failure) 35%. Reason: a well-resourced internal channel, but one month is short for convincing ablations, and open publication of the paper and eval suite needs internal review that may not clear this month.

Action 2 [Governance/release memos to leadership]: P(failure) 30%. Reason: the memo channel is reliable and the pre-release testing and system card advice matches existing practice. The LTBT public statement and KYC layer are the uncertain parts, and the backlash risk is modelled separately in Threat 1.

Action 3 [Incident-reporting bill + pacing options paper]: P(failure) 45%. Reason: drafting is easy, but the December transition means no sponsors, and meaningful uptake depends on human staff choices over the coming weeks.

Action 4 [Defensive cyber for hospitals/OSS]: P(failure) 35%. Reason: Glasswing infrastructure exists and the partners are willing. CISA vetting and partner onboarding limit scale to a small pilot.

Action 5 [DNA-screening tool + FMF incident exchange]: P(failure) 45%. Reason: the FMF proposal is easy, but a validated, obfuscation-robust screening tool ready for open release in one month is ambitious and needs biosecurity review.

Action 6 [Labour transition help + costed-policy report]: P(failure) 35%. Reason: in-product changes are quick. A report with costed policy options on a one-month timeline is plausible but often slips, and the trust payoff is diffuse.
</action_odds>

<threat_odds>
Threat 1 [Founder LLC backlash overtakes LTBT memo]: P(materialises) 35%. Adversary suggested 40%. Reason for lowering it: criticism of the Founder LLC is real and ongoing. However, becoming the dominant December story, rather than a background story, needs a news hook such as an S-1 amendment or a hearing, and the new House majority only takes the gavel in January. The KYC layer not shipping this month is already expected under Action 2 and adds no extra risk.

Threat 2 ["AI writing its own regulation" exposure]: P(materialises) 20%. Adversary suggested 35%. Reason for lowering it: the Sacks line of attack is established, but this threat needs a specific leak or reveal that becomes a news cycle within December. Staff consulting Claude is widespread and low-salience, and the drafts are nonpartisan and publicly available.

Threat 3 [Maintainer overload / n-day window]: P(materialises) 30%. Adversary suggested 45% for friction and 10–15% for exploitation. Reason for the combined figure: a December pilot would be small, which limits volume. The documented CVE-treadmill backlash still makes public maintainer friction a real risk. A publicised exploitation within the month is only a small share of this figure.

Threat 4 [Eval-awareness confounds results; adoption deferred]: P(materialises) 45%. Adversary suggested 50%. Reason for lowering it slightly: eval-awareness is well documented and deferral to a pilot under race pressure is the base-rate outcome. Anthropic has internal tooling to partially control for eval-awareness, so fully uninterpretable results are somewhat less likely.

Threat 5 [Legal chill on incident exchange; bio-screen gating]: P(materialises) 45%. Adversary suggested 45%, and my independent estimate matches. Reason: there are two independent, well-grounded failure paths. Lab lawyers are cautious given RAISE and SB 53 reporting duties and the House investigation. Biosecurity norms strongly favour gated release, as in the Microsoft/IBBIS precedent. Either path alone counts as the threat materialising.
</threat_odds>
